Terazosin Hydrochloride Capsule
Product Images NDC 87564-084

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Terazosin Hydrochloride (NDC 87564-084). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amerisyn Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (39aed07c 03ae 4d1d B853 0c9932fa8e6c 01)

Chemical structure of terazosin hydrochloride, showing its molecular framework including aromatic rings, nitrogen atoms, and functional groups characteristic of this active ingredient.*

FDA Label Image

Image (39aed07c 03ae 4d1d B853 0c9932fa8e6c 02)

Two line charts comparing placebo and terazosin treatment effects over three months. The left chart shows mean change in total symptom score from baseline, with terazosin reducing symptoms more than placebo. The right chart shows mean increase in peak flow rate (mL/sec) from baseline, with terazosin producing a greater increase compared to placebo.*

FDA Label Image

Image (39aed07c 03ae 4d1d B853 0c9932fa8e6c 03)

A line graph depicting the mean change from baseline over a 30-month period. The x-axis represents time in months, while the y-axis shows the mean change values. The graph includes multiple data points marked with symbols to indicate statistical significance at various time points.*

FDA Label Image

Image (39aed07c 03ae 4d1d B853 0c9932fa8e6c 04)

A line graph showing mean change from baseline in mL/sec over time in months, from month 0 to 30. Data points are plotted monthly with standard deviation error bars. Several time points are marked with asterisks, potentially indicating significance.*

FDA Label Image

Image (39aed07c 03ae 4d1d B853 0c9932fa8e6c 05)

Label for Terazosin Capsules, USP 1 mg by Amerisyn LLC. The label includes the NDC number 87564-081-10 and states the medication is in capsule form for oral use. It provides storage instructions, dosage guidance to see the package insert, and notes that the package contains 100 capsules. The label also features a barcode and the Amerisyn logo in red and blue colors.*

FDA Label Image

Image (39aed07c 03ae 4d1d B853 0c9932fa8e6c 06)

Label for Terazosin Capsules, USP 1 mg oral capsules manufactured by Amerisyn LLC. The label indicates each capsule contains 1 mg terazosin hydrochloride, with storage instructions to keep at 20-25°C and protect from light and moisture. The package size is 1000 capsules. The label includes the NDC 87564-081-01 and a barcode.*

FDA Label Image

Image (39aed07c 03ae 4d1d B853 0c9932fa8e6c 07)

Label for Terazosin Capsules, USP 2 mg by Amerisyn LLC. The label includes NDC 87564-082-10 and states each capsule contains 2 mg terazosin hydrochloride. It specifies storage instructions, patient dispensing guidance, and a barcode. The label also notes a package size of 100 capsules and includes the Amerisyn logo.*

FDA Label Image

Image (39aed07c 03ae 4d1d B853 0c9932fa8e6c 08)

Label for Terazosin Capsules USP 2 mg by Amerisyn LLC. The label includes the NDC 87564-082-01 and states the active ingredient is terazosin hydrochloride equivalent to 2 mg terazosin per capsule. It contains storage instructions, a barcode, and the labeler information for Amerisyn LLC, Greensboro, NC. The package size indicated is 1000 capsules.*

FDA Label Image

Image (39aed07c 03ae 4d1d B853 0c9932fa8e6c 09)

Label for Terazosin Capsules, USP 5 mg, an oral human prescription drug by Amerisyn LLC. The label displays the NDC 87564-083-10 and states the active ingredient as terazosin hydrochloride equivalent to 5 mg per capsule. The label includes dispensing instructions, storage recommendations (20° to 25°C), a barcode, and the quantity of 100 capsules. The label uses black and green text on a white background and includes the Amerisyn logo.*

FDA Label Image

Image (39aed07c 03ae 4d1d B853 0c9932fa8e6c 10)

Label for Terazosin Capsules, USP 5 mg oral capsules by Amerisyn LLC. The label shows the NDC number 87564-083-01, quantity of 1000 capsules, and storage instructions. It includes a barcode and states the active ingredient as terazosin hydrochloride equivalent to 5 mg terazosin. The label advises dispensing with a medication guide and keeping out of reach of children.*

FDA Label Image

Image (39aed07c 03ae 4d1d B853 0c9932fa8e6c 11)

Label for Terazosin Capsules, USP 10 mg oral capsules by Amerisyn LLC. The label includes the NDC 87564-084-10, directions to dispense with a medication guide, storage instructions, and a barcode. The package contains 100 capsules. The label background is primarily white with an orange bar highlighting the 10 mg strength.*

FDA Label Image

Image (39aed07c 03ae 4d1d B853 0c9932fa8e6c 12)

Label for Terazosin Capsules, USP 10 mg by Amerisyn LLC. The label states the capsule strength as 10 mg and lists the National Drug Code (NDC) 87564-084-01. It instructs pharmacists to dispense the medication guide separately to each patient. Storage instructions specify a temperature of 20° to 25°C (68° to 77°F), protecting from light and moisture. The package contains 1000 capsules. The label includes a barcode and notes it is for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.